NEUP short interest
Neuphoria Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 20,022 |
|---|---|
| Change vs prior report | -4,691 (-19.0%) |
| Change over six months | -25.4% |
| Days to cover | 1.61 (sector: 3.78) |
| Average daily volume | 12,424 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
NEUP short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 20,022 | -19.0% | 1.61 | 12,424 |
| 2026-09-15 | 24,713 | -61.8% | 1.22 | 20,204 |
| 2026-08-31 | 64,641 | +53.8% | 1.00 | 67,695 |
| 2026-08-14 | 42,034 | -35.9% | 1.46 | 28,832 |
| 2026-07-31 | 65,538 | +327.4% | 1.00 | 638,720 |
| 2026-07-15 | 15,334 | -3.1% | 1.00 | 109,747 |
| 2026-06-30 | 15,831 | -31.3% | 1.00 | 78,309 |
| 2026-06-15 | 23,029 | -37.5% | 1.00 | 76,196 |
| 2026-05-29 | 36,835 | +88.0% | 1.00 | 59,827 |
| 2026-05-15 | 19,598 | -57.4% | 1.00 | 28,089 |
| 2026-04-30 | 46,010 | +97.4% | 1.46 | 31,445 |
| 2026-04-15 | 23,312 | -13.2% | 1.00 | 54,219 |
| 2026-03-31 | 26,849 | +118.0% | 1.00 | 53,661 |
| 2026-03-13 | 12,316 | -14.0% | 1.00 | 86,687 |
| 2026-02-27 | 14,323 | -56.8% | 1.00 | 31,057 |
| 2026-02-13 | 33,185 | -10.3% | 1.63 | 20,386 |
| 2026-01-30 | 36,994 | -9.2% | 1.00 | 41,083 |
| 2026-01-15 | 40,719 | +64.3% | 1.00 | 51,051 |
| 2025-12-31 | 24,781 | +14.1% | 1.00 | 57,190 |
| 2025-12-15 | 21,719 | -66.7% | 1.00 | 101,515 |
| 2025-11-28 | 65,284 | -60.8% | 1.00 | 77,440 |
| 2025-11-14 | 166,591 | -45.2% | 1.00 | 275,731 |
| 2025-10-31 | 304,261 | +2133.6% | 1.00 | 7,722,000 |
| 2025-10-15 | 13,622 | -45.8% | 1.00 | 110,795 |
| 2025-09-30 | 25,130 | -14.3% | 1.00 | 74,545 |
import finzdata as yf
yf.Ticker("NEUP").short_interest # every report since 2017
yf.Client().short_interest(["NEUP"], start="2018-01-01")Healthcare short interest · NEUP price history · Who owns NEUP · All short interest